MOTS-c Dosage: Complete Guide to Protocols, Reconstitution & Administration

MOTS-c dosing differs meaningfully from most other peptide protocols. It is not a daily injection or a simple weekly dose — it uses a pulsed, cyclical protocol designed to mirror the natural episodic release of MOTS-c during metabolic stress. Understanding this structure is central to getting the most from treatment.

Key takeaways
  • Typical MOTS-c doses are 5–10 mg administered 1–3 times per week via subcutaneous injection
  • The most common clinical protocol is 5 mg every 5 days for 20 days (4 injections per cycle), repeated 2–4 times per year
  • MOTS-c is highly unstable after reconstitution — use within 7 days for best potency; this is shorter than most other peptides
  • Bacteriostatic water is required for reconstitution — sterile water degrades MOTS-c more rapidly
  • Never freeze reconstituted MOTS-c; refrigerate immediately and protect from light
  • Nutrition timing and diet quality directly affect how well AMPK activation translates into metabolic outcomes — low-carbohydrate or fasted states before injection may enhance effect
  • All protocols are physician-supervised and personalized based on metabolic goals and individual response
Is MOTS-c Therapy right for you?
Join Waitlist

Standard Dosing Protocols

MOTS-c is not taken continuously like a daily supplement. Its mechanism — AMPK activation mimicking the metabolic stress of exercise or caloric restriction — is best achieved through pulsed protocols that allow the pathway to reset between doses.

Standard protocol: 5 mg every 5 days for 20 days (4 total injections per cycle). This cycle is typically repeated 2–4 times per year based on your physician's assessment of response and goals.

Higher-dose protocol: 10 mg administered 2–3 times per week during active treatment cycles. Used for patients with more significant metabolic dysfunction or when a more aggressive initial response is clinically indicated.

Maintenance protocol: After an initial active cycle, some patients move to a lower frequency maintenance schedule — 5 mg once weekly — to sustain AMPK activation without continuous cycling. Your physician determines whether maintenance or full cycling is appropriate.

For the complete dosing framework with worked calculation examples, vial concentration tables, and syringe unit math, see the MOTS-c Dosage Calculator →.

Reconstitution: Critical Stability Notes

MOTS-c is more chemically unstable after reconstitution than most other peptides. This requires strict handling.

Use bacteriostatic water only — sterile water accelerates peptide degradation. Reconstituted MOTS-c must be used within 7 days for reliable potency — this is significantly shorter than the 28-day window for TB-500 or GHK-Cu. Refrigerate immediately after mixing, protect from light, and never freeze. Never shake the vial — roll gently to dissolve.

The solution should be clear and colorless. Discard if cloudy, discolored, or if particles are visible. Because of the short stability window, vial size selection should match your planned use within the 7-day period — do not reconstitute more than you will use.

All MOTS-c therapy plans are tailored by licensed physicians to fit your unique health needs.

Find out if MOTS-c therapy is right for your goals.

Join Waitlist

Injection Technique

MOTS-c is administered subcutaneously — into fatty tissue beneath the skin at the abdomen, outer thigh, or upper arm. The injection technique is standard: clean the site with an alcohol swab, allow to dry, pinch a fold of skin, insert at 45–90°, inject slowly, remove and apply gentle pressure without rubbing, and dispose of the needle in a sharps container.

Rotate injection sites with every dose. MOTS-c does not need to be injected near any specific target tissue — it acts systemically via AMPK activation throughout the body.

Nutrition and Lifestyle Support

Factor Recommendation Why It Matters
Injection timing Consider injecting in a fasted state or before exercise when possible AMPK activation is enhanced when cellular energy status is already low — fasting and exercise both prime this state
Carbohydrate intake Lower-carbohydrate dietary patterns amplify MOTS-c metabolic effects Chronic high carbohydrate intake maintains elevated insulin and suppresses AMPK — reducing the cellular response to MOTS-c
Protein intake Adequate protein (0.8–1.0 g per lb of lean body mass) during treatment cycles AMPK activation supports fat oxidation but lean mass preservation requires adequate protein substrate
Exercise Regular aerobic and resistance exercise during treatment cycles Exercise and MOTS-c activate AMPK through complementary pathways — the combination produces greater metabolic adaptation than either alone

For the complete nutritional framework for supporting MOTS-c therapy, see Nutrition & Diet Recommendations to Support MOTS-c Therapy →.

Frequently Asked Questions

Why is MOTS-c dosed in cycles rather than daily?

MOTS-c works by activating AMPK — a pathway that is naturally pulsatile and resets between activations. Continuous daily dosing can blunt receptor sensitivity. The cyclical protocol mimics how the body naturally uses MOTS-c during periods of metabolic stress.

Why is the stability window only 7 days?

MOTS-c's molecular structure is more susceptible to degradation after reconstitution than peptides like TB-500 or sermorelin. The 7-day window is not a regulatory limit — it is a potency preservation guideline. After 7 days, the peptide may still be chemically present but biological activity degrades.

Can I inject MOTS-c at any time of day?

Yes, with no hard timing requirement. However, injecting in a fasted state or before exercise may enhance AMPK activation by priming the low-energy cellular environment that MOTS-c works best in.

What if I miss a dose in my cycle?

Take the missed dose as soon as you remember and reset the 5-day interval from that point. Do not double dose. If the reconstituted solution is past 7 days, prepare a fresh vial.

Join the MOTS-c Waitlist
MOTSc.com is launching physician-supervised MOTS-c therapy soon. Join the waitlist now for early access, exclusive pricing, and immediate notification when we go live.
Join Waitlist

Disclaimer

This content is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. MOTS-c is an investigational compound available through licensed U.S. compounding pharmacies via physician prescription. It has not been approved by the FDA. Compounded medications are not FDA-reviewed for safety, quality, or efficacy. Consult a licensed healthcare provider before starting, changing, or stopping any treatment. Individual results vary.

Is MOTS-c Therapy right for you?
Join Waitlist